Back to VA Vanguard Capital Management LLC
KRYS
2 quarters
Position history for VAVanguard Capital Management LLC's holdings in Krystal Biotech, Inc.
Yes. Vanguard Capital Management holds 1,240,567 shares of KRYS (Krystal Biotech), worth $461.1M, as of its Q2 2026 13F filing. It increased the position by 75,243 shares (+6.5%) from Q1 2026. Vanguard Capital Management has held KRYS in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$461.1M
Current Shares
1.2M
Total Value Change
+$160.1M
Total Shares Change
+75,243
Quarter-by-Quarter History
Other major holders of KRYS: FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC